Astellas Pharma (Japan)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. On February 5, 2020, the company announced management changes effective from April 1, 2020.Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Japan), Japan, covering academic research published from 2000 to 2022. Read More.
Open Access Percentage
52%
Total
Publications
4.1K
Total Open
Publications
2.1K
Total
Citations
99K
Open Access
Percentage
52%
Total
Publications
4.1K
Total Open
Publications
2.1K
Total
Citations
99K
Breakdown
Publisher Open
25%
Both
22%
Other Platform Open
5%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
406
Hybrid 43%
822
No Guarantees 36%
678
Other Platform Open
Domain 86%
954
Institution 20%
223
Public 10%
114
Other Internet 6%
68
Preprint 3%
34
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 953 |
Europe PMC | Domain | 673 |
Semantic Scholar | Public | 87 |
Figshare | Public | 55 |
DOI | Other Internet | 35 |
University College London - UCL Discovery | Institution | 21 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 20 |
California Digital Library - eScholarship | Other Internet | 18 |
University of Bristol - Bristol Research | Institution | 17 |
KU Leuven - Lirias | Institution | 17 |